• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠靶向给药系统——综述

Colon targeted drug delivery systems--an overview.

作者信息

Kumar P, Mishra B

机构信息

Department of Pharmaceutics Institute of Technology Banaras Hindu University, Varanasi-221005, India.

出版信息

Curr Drug Deliv. 2008 Jul;5(3):186-98. doi: 10.2174/156720108784911712.

DOI:10.2174/156720108784911712
PMID:18673262
Abstract

In the last two decades colon targeted drug delivery has gained increased importance not just for the deliver drugs for the treatment of various colonic diseases but also for its potential for delivery of proteins and therapeutic peptides. In the past various traditional approaches used for colon targeted delivery like prodrugs, pH, time dependent, and microflora activated systems, have achieved limited success. For successful colon targeted drug delivery, the drug needs to be protected from absorption and/or the environment of the upper gastrointestinal tract and then be abruptly released into the colon. Hence continuous efforts have been made on designing colon targeted drug delivery systems with improved site specificity and versatile drug release kinetics to fulfill different therapeutic needs. In last couple of years few new systems have been developed for colon targeted drug delivery such as pressure dependent systems, CODES technology, microsponges, pectin and galactomannan coating, microbially triggered osmotic systems, lectins and neoglyconjugated etc. which are reported to have better in-vivo site specificity and design rationale than the earlier approaches. This review article gives an overview of various approaches for colonic targeted drug delivery with emphasis on newer systems, their merits and demerits, in vitro/ in-vivo evaluation and market status of such delivery systems.

摘要

在过去二十年中,结肠靶向给药不仅在递送用于治疗各种结肠疾病的药物方面变得越来越重要,而且在递送蛋白质和治疗性肽方面也具有潜力。过去,用于结肠靶向递送的各种传统方法,如前体药物、pH值依赖、时间依赖和微生物激活系统,取得的成功有限。为了实现成功的结肠靶向给药,药物需要避免在上消化道被吸收和/或免受其环境影响,然后突然释放到结肠中。因此,人们一直在不断努力设计具有更高位点特异性和通用药物释放动力学的结肠靶向给药系统,以满足不同的治疗需求。在过去几年中,已经开发了一些用于结肠靶向给药的新系统,如压力依赖系统、CODES技术、微海绵、果胶和半乳甘露聚糖包衣、微生物触发渗透系统、凝集素和新糖缀合物等,据报道这些系统比早期方法具有更好的体内位点特异性和设计原理。这篇综述文章概述了结肠靶向给药的各种方法,重点介绍了较新的系统、它们的优缺点、体外/体内评估以及此类给药系统的市场状况。

相似文献

1
Colon targeted drug delivery systems--an overview.结肠靶向给药系统——综述
Curr Drug Deliv. 2008 Jul;5(3):186-98. doi: 10.2174/156720108784911712.
2
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.
3
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.结肠特异性药物递送:新方法及体外/体内评价
Int J Pharm. 2002 Mar 20;235(1-2):1-15. doi: 10.1016/s0378-5173(02)00004-2.
4
Target-specific drug release to the colon.靶向结肠的药物释放。
Expert Opin Drug Deliv. 2008 May;5(5):483-98. doi: 10.1517/17425247.5.5.483.
5
Polysaccharides for colon targeted drug delivery.用于结肠靶向给药的多糖。
Drug Deliv. 2004 Mar-Apr;11(2):129-48. doi: 10.1080/10717540490280778.
6
Azo chemistry and its potential for colonic delivery.偶氮化学及其在结肠递送方面的潜力。
Crit Rev Ther Drug Carrier Syst. 2006;23(5):349-400. doi: 10.1615/critrevtherdrugcarriersyst.v23.i5.10.
7
Colon-targeted oral drug delivery systems: design trends and approaches.结肠靶向口服给药系统:设计趋势与方法
AAPS PharmSciTech. 2015 Aug;16(4):731-41. doi: 10.1208/s12249-015-0350-9. Epub 2015 Jun 13.
8
Microbially triggered drug delivery to the colon.微生物触发的药物向结肠的递送。
Eur J Pharm Sci. 2003 Jan;18(1):3-18. doi: 10.1016/s0928-0987(02)00221-x.
9
Advances in colonic drug delivery.结肠给药的进展。
Drugs. 2005;65(14):1991-2007. doi: 10.2165/00003495-200565140-00006.
10
Colon Cancer and Specific Ways to Deliver Drugs to the Large Intestine.结肠癌及向大肠给药的特定方式。
Anticancer Agents Med Chem. 2017;17(10):1317-1327. doi: 10.2174/1871520617666170213142030.

引用本文的文献

1
A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease.姜黄素结肠靶向口服给药系统治疗炎症性肠病的研究进展。
Inflammopharmacology. 2023 Jun;31(3):1095-1105. doi: 10.1007/s10787-023-01140-0. Epub 2023 Feb 9.
2
Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges.壳聚糖/海藻酸钠纳米粒子在口服给药系统中的应用:前景与挑战。
Drug Deliv. 2022 Dec;29(1):1142-1149. doi: 10.1080/10717544.2022.2058646.
3
Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring.
下消化道中的药物处置:靶向与监测
Pharmaceutics. 2021 Jan 26;13(2):161. doi: 10.3390/pharmaceutics13020161.
4
Controlled drug release for inflammatory bowel disease (IBD).用于炎症性肠病(IBD)的控释药物
Bioinformation. 2020 Jul 31;16(7):513-524. doi: 10.6026/97320630016513. eCollection 2020.
5
A new prodrug and bioactivity evaluation of methotrexate based on Chitosan.基于壳聚糖的甲氨蝶呤新型前药及其生物活性评价
Heliyon. 2020 Jun 18;6(6):e04223. doi: 10.1016/j.heliyon.2020.e04223. eCollection 2020 Jun.
6
Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs.壳聚糖-1-乙酸-5-氟尿嘧啶缀合物的制备及生物活性评价作为癌症前药。
Molecules. 2017 Nov 8;22(11):1629. doi: 10.3390/molecules22111629.
7
Colon-targeted oral drug delivery systems: design trends and approaches.结肠靶向口服给药系统:设计趋势与方法
AAPS PharmSciTech. 2015 Aug;16(4):731-41. doi: 10.1208/s12249-015-0350-9. Epub 2015 Jun 13.
8
Production of recombinant human growth hormone conjugated with a transcytotic peptide in Pichia pastoris for effective oral protein delivery.在毕赤酵母中生产与转胞吞肽偶联的重组人生长激素用于有效的口服蛋白质递送。
Mol Biotechnol. 2015 May;57(5):430-8. doi: 10.1007/s12033-014-9835-0.
9
Design, development, and optimization of polymeric based-colonic drug delivery system of naproxen.萘普生基于聚合物的结肠给药系统的设计、开发与优化。
ScientificWorldJournal. 2013 Oct 1;2013:654829. doi: 10.1155/2013/654829. eCollection 2013.
10
Approaches for enhancing oral bioavailability of peptides and proteins.提高肽和蛋白质口服生物利用度的方法。
Int J Pharm. 2013 Apr 15;447(1-2):75-93. doi: 10.1016/j.ijpharm.2013.02.030. Epub 2013 Feb 18.